Full-Time

Director – Purification Process Sciences

Confirmed live in the last 24 hours

Deadline 7/28/25
AstraZeneca

AstraZeneca

10,001+ employees

Develops and commercializes prescription medicines

Compensation Overview

$171.4k - $257.1k/yr

+ Short-term Incentive Bonus + Equity-based Long-term Incentive Program

Expert

Gaithersburg, MD, USA

Hybrid

In-person working gives us the platform we need to connect, work at pace and challenge perceptions. That's why we work, on average, a minimum of three days per week from the office.

Category
Biology Lab & Research
Biology & Biotech
Requirements
  • Ph.D. or equivalent in chemistry/biochemistry, chemical/biochemical engineering, or related discipline, with 11+ years of relevant experience with PhD (15+ years with BS/MS).
  • Established expertise in a biopharmaceutical company in purification process development and tech transfer for biological products.
  • Excellent oral and written communication skills.
  • Proven ability to work effectively in cross-functional matrix organization, demonstrating a positive attitude and strong influencing skills.
  • Prior supervisory experience is required (line management and/or matrix management). Experience as an effective leader and coach for a diverse team of staff members.
  • Demonstrated experience progressing biopharmaceutical products to licensure.
  • Good working knowledge of drug development, including protein chemistry, protein purification, process design, with demonstrated independence and problem-solving capability.
  • Deep understanding of all downstream unit operations, with a proven track record of innovation and technical excellence.
Responsibilities
  • Set direction and objectives for a team of scientists focused on purification process development.
  • Design, optimize, and characterize downstream processes for manufacturing protein therapeutics across all development stages.
  • Innovate clinical and commercial manufacturing approaches for biopharmaceuticals and drive continuous platform improvements.
  • Represent BPD in regulatory communications and AZ senior leadership meetings, while leading purification development for diverse drug candidates from clinical development through registration.
  • Coordinate with cross-functional teams to meet project timelines and company goals.
  • Prepare regulatory documents and address health authority queries with a strong understanding of GMP and Quality issues.
  • Supervise downstream development activities for multiple projects, ensuring delivery within a matrixed organization.
  • Author and review key documents for process development strategies.
  • Advance AZ’s scientific approaches through industry participation and publications.
  • Mentor team members, equipping them with skills to contribute to AZ's mission.
Desired Qualifications
  • Recognized as a scientific thought leader in developing purification processes for complex, non-mAb molecules and new modalities.
  • Demonstrated organizational and strategic leadership in establishing technical guidelines and business processes, as well as steering cross-organizational alignment within and outside of biologics CMC development.
  • Experience in developing late-stage strategies, with good understanding of Regulatory guidance and Quality systems.
  • Fundamental understanding of bioprocess design and mechanistic modeling for chromatographic and/or membrane processes.
  • Experience in downstream process intensification, high-throughput and automation technologies, database and digitalization tools.

AstraZeneca focuses on discovering, developing, and selling prescription medicines. The company specializes in three main areas: Oncology, which deals with cancer treatment; Cardiovascular, Renal & Metabolism, which addresses heart, kidney, and metabolic diseases; and Respiratory & Immunology, which targets lung and immune system diseases. Their products are developed through extensive research and development, followed by clinical trials and regulatory approvals before reaching the market. AstraZeneca distinguishes itself from competitors by investing heavily in scientific research and forming strategic partnerships to enhance drug discovery. Their goal is to advance healthcare by creating effective treatments for serious diseases and collaborating with other organizations to improve their research capabilities.

Company Size

10,001+

Company Stage

IPO

Headquarters

Cambridge, United Kingdom

Founded

1913

Simplify Jobs

Simplify's Take

What believers are saying

  • AstraZeneca's AI partnership with Sheffield enhances protein folding and drug discovery.
  • The expansion in Bangalore creates 400 jobs, boosting AstraZeneca's global operations.
  • Strategic stake in Niox Group offers collaboration opportunities in the pharmaceutical sector.

What critics are saying

  • Expansion in Bangalore may face challenges from local regulatory changes.
  • Stake in Niox Group exposes AstraZeneca to financial risks if Niox underperforms.
  • CSPC collaboration may be affected by geopolitical tensions or trade restrictions.

What makes AstraZeneca unique

  • AstraZeneca focuses on three main therapy areas: Oncology, Cardiovascular, and Respiratory.
  • The company invests heavily in R&D to create innovative prescription medicines.
  • AstraZeneca's A.Catalyst Network fosters global collaboration and innovation in healthcare.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Flexible Work Hours

Company News

HRKatha
Jun 27th, 2025
AstraZeneca creates 400 jobs, expands its global hub in Bangalore

AstraZeneca creates 400 jobs, expands its global hub in Bangalore.

Devdiscourse
Jun 18th, 2025
AstraZeneca's Stake in Niox Group: A Strategic Partnership | Headlines

AstraZeneca PLC has acquired a significant stake of 15.86% in Niox Group PLC, according to a recent company filing. This move signals strategic collaboration opportunities between the two companies, potentially aligning their interests in the pharmaceutical industry and expanding their influence in the sector.

InfBusiness
Jun 17th, 2025
Scientists present AI solution for protein folding

Scientists from the University of Sheffield, in partnership with AstraZeneca, have developed an artificial intelligence system called MapDiff, which allows for more efficient creation of proteins with a giventhree-dimensional structure and biological functions.

Cision
Jun 13th, 2025
Astrazeneca Enters Into Collaboration With Cspc

AstraZeneca enters into collaboration with CSPC

Cision
Jun 6th, 2025
Fixed-Duration Calquence Approved In Eu For 1L Cll

Fixed-duration Calquence approved in EU for 1L CLL